Literature DB >> 29669251

Self-Renewal and Toll-like Receptor Signaling Sustain Exhausted Plasmacytoid Dendritic Cells during Chronic Viral Infection.

Monica Macal1, Yeara Jo1, Simone Dallari1, Aaron Y Chang1, Jihong Dai2, Shobha Swaminathan3, Ellen J Wehrens1, Patricia Fitzgerald-Bocarsly2, Elina I Zúñiga4.   

Abstract

Although characterization of T cell exhaustion has unlocked powerful immunotherapies, the mechanisms sustaining adaptations of short-lived innate cells to chronic inflammatory settings remain unknown. During murine chronic viral infection, we found that concerted events in bone marrow and spleen mediated by type I interferon (IFN-I) and Toll-like receptor 7 (TLR7) maintained a pool of functionally exhausted plasmacytoid dendritic cells (pDCs). In the bone marrow, IFN-I compromised the number and the developmental capacity of pDC progenitors, which generated dysfunctional pDCs. Concurrently, exhausted pDCs in the periphery were maintained by self-renewal via IFN-I- and TLR7-induced proliferation of CD4- subsets. On the other hand, pDC functional loss was mediated by TLR7, leading to compromised IFN-I production and resistance to secondary infection. These findings unveil the mechanisms sustaining a self-perpetuating pool of functionally exhausted pDCs and provide a framework for deciphering long-term exhaustion of other short-lived innate cells during chronic inflammation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV; LCMV; TLR; cancer; chronic viral infection; exhaustion; plasmacytoid dendritic cells; type I interferon

Mesh:

Substances:

Year:  2018        PMID: 29669251      PMCID: PMC5937984          DOI: 10.1016/j.immuni.2018.03.020

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  69 in total

1.  Plasmacytoid dendritic cells are productively infected and activated through TLR-7 early after arenavirus infection.

Authors:  Mónica Macal; Gavin M Lewis; Stefan Kunz; Richard Flavell; James A Harker; Elina I Zúñiga
Journal:  Cell Host Microbe       Date:  2012-06-14       Impact factor: 21.023

2.  Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual.

Authors:  Melissa Swiecki; Susan Gilfillan; William Vermi; Yaming Wang; Marco Colonna
Journal:  Immunity       Date:  2010-12-02       Impact factor: 31.745

3.  Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation.

Authors:  Thomas H Vanderford; Chloe Slichter; Kenneth A Rogers; Benton O Lawson; Rend Obaede; James Else; Francois Villinger; Steven E Bosinger; Guido Silvestri
Journal:  Blood       Date:  2012-05-01       Impact factor: 22.113

Review 4.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

5.  Bone marrow-imprinted gut-homing of plasmacytoid dendritic cells (pDCs) in acute simian immunodeficiency virus infection results in massive accumulation of hyperfunctional CD4+ pDCs in the mucosae.

Authors:  Haiying Li; Tristan I Evans; Jacqueline Gillis; Michelle Connole; R Keith Reeves
Journal:  J Infect Dis       Date:  2014-12-08       Impact factor: 5.226

6.  TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function.

Authors:  Anne Krug; Anthony R French; Winfried Barchet; Jens A A Fischer; Andrzej Dzionek; Jeanette T Pingel; Michael M Orihuela; Shizuo Akira; Wayne M Yokoyama; Marco Colonna
Journal:  Immunity       Date:  2004-07       Impact factor: 31.745

7.  CD28 Deficiency Enhances Type I IFN Production by Murine Plasmacytoid Dendritic Cells.

Authors:  Monica Macal; Miguel A Tam; Charles Hesser; Jeremy Di Domizio; Psylvia Leger; Michel Gilliet; Elina I Zuniga
Journal:  J Immunol       Date:  2016-01-15       Impact factor: 5.422

8.  Recognition of single-stranded RNA viruses by Toll-like receptor 7.

Authors:  Jennifer M Lund; Lena Alexopoulou; Ayuko Sato; Margaret Karow; Niels C Adams; Nicholas W Gale; Akiko Iwasaki; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

9.  Slc15a4, a gene required for pDC sensing of TLR ligands, is required to control persistent viral infection.

Authors:  Amanda L Blasius; Philippe Krebs; Brian M Sullivan; Michael B Oldstone; Daniel L Popkin
Journal:  PLoS Pathog       Date:  2012-09-13       Impact factor: 6.823

10.  Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.

Authors:  Isabelle E Vincent; Claudia Zannetti; Julie Lucifora; Helene Norder; Ulrike Protzer; Pierre Hainaut; Fabien Zoulim; Massimo Tommasino; Christian Trépo; Uzma Hasan; Isabelle Chemin
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

View more
  16 in total

1.  IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE.

Authors:  Dan Li; Bharati Matta; Su Song; Victoria Nelson; Kirsten Diggins; Kim R Simpfendorfer; Peter K Gregersen; Peter Linsley; Betsy J Barnes
Journal:  JCI Insight       Date:  2020-01-30

Review 2.  Emerging concepts of type I interferons in SLE pathogenesis and therapy.

Authors:  Antonios Psarras; Miriam Wittmann; Edward M Vital
Journal:  Nat Rev Rheumatol       Date:  2022-09-12       Impact factor: 32.286

3.  Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19.

Authors:  Yunlong Ma; Yukuan Huang; Sen Zhao; Yinghao Yao; Yaru Zhang; Jia Qu; Nan Wu; Jianzhong Su
Journal:  Hum Mol Genet       Date:  2021-06-17       Impact factor: 6.150

Review 4.  Immunology of SARS-CoV-2 infection in children.

Authors:  Janet Chou; Paul G Thomas; Adrienne G Randolph
Journal:  Nat Immunol       Date:  2022-02-01       Impact factor: 31.250

Review 5.  Immune cell subset differentiation and tissue inflammation.

Authors:  Pu Fang; Xinyuan Li; Jin Dai; Lauren Cole; Javier Andres Camacho; Yuling Zhang; Yong Ji; Jingfeng Wang; Xiao-Feng Yang; Hong Wang
Journal:  J Hematol Oncol       Date:  2018-07-31       Impact factor: 17.388

6.  Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery.

Authors:  Birgitte Stiksrud; Hans C D Aass; Kristina B Lorvik; Thor Ueland; Marius Trøseid; Anne M Dyrhol-Riise
Journal:  AIDS       Date:  2019-06-01       Impact factor: 4.177

Review 7.  What Makes a pDC: Recent Advances in Understanding Plasmacytoid DC Development and Heterogeneity.

Authors:  Andrea Musumeci; Konstantin Lutz; Elena Winheim; Anne Barbara Krug
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

Review 8.  Plasmacytoid Dendritic Cells: Development, Regulation, and Function.

Authors:  Boris Reizis
Journal:  Immunity       Date:  2019-01-15       Impact factor: 31.745

9.  TLR4 signaling improves PD-1 blockade therapy during chronic viral infection.

Authors:  Yidan Wang; Young Rock Chung; Simon Eitzinger; Nicole Palacio; Shana Gregory; Mitra Bhattacharyya; Pablo Penaloza-MacMaster
Journal:  PLoS Pathog       Date:  2019-02-06       Impact factor: 6.823

10.  Regulation of Transcription Factor E2-2 in Human Plasmacytoid Dendritic Cells by Monocyte-Derived TNFα.

Authors:  Hannah K Dewald; Harry J Hurley; Patricia Fitzgerald-Bocarsly
Journal:  Viruses       Date:  2020-01-31       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.